On 17th November 2024, Laketown Synergy proudly hosted Divination, a premier event dedicated to advancing diabetes care. Sponsored by Novo Nordisk, a global leader in diabetes management, this evening brought together distinguished experts and professionals from the medical fraternity. Held from 8:00 PM to 10:00 PM, Divination was designed to explore groundbreaking strategies and foster dialogue on critical topics in diabetes care, aiming to benefit healthcare providers and patients alike.
The event commenced with an insightful welcome by Dr. Sudip Chatterjee, setting the stage for a thought-provoking evening. Dr. Sujoy Majumder followed with a session on innovative glycemic management strategies, offering practical approaches to optimize patient care. Next, Dr. Soumyabrata Roy Choudhury explored the potential of oral semaglutide, emphasizing its dual benefits in managing Type 2 Diabetes (T2D) and cardiovascular risks. Adding to the rich discussion, Dr. Debmalya Sanyal presented a compelling case-based analysis on T2D patients with Non-Alcoholic Steatohepatitis (NASH), highlighting the importance of an integrated treatment approach. The evening’s momentum continued with an engaging expert talk show featuring Dr. Arindam Pandy, Dr. B.P. Pandey, Dr. Atanu Pal, and Dr. Samit Ghoshal, who shared their experiences on the therapeutic triumphs of GLP-1 Receptor Agonists (GLP-1RAs). The event concluded with a thoughtful summary by Dr. Sudip Chatterjee, capturing key insights and reaffirming the shared commitment to advancing diabetes care.
Laketown Synergy extends its heartfelt gratitude to Novo Nordisk for their invaluable sponsorship and to our esteemed speakers for their expert contributions. A special thanks to the organizers and staff whose dedication made Divination a resounding success. Together, we are shaping the future of diabetes care. Stay tuned for more impactful events as we continue to lead the way in healthcare excellence.
